Navigation Links
Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week
Date:1/31/2011

BEVERLY HILLS, Calif., Jan. 31, 2011 /PRNewswire/ -- OXIS International, Inc., (OTC Bulletin Board: OXIS; Euronext Paris: OXI) today announced highly favorable final results from an initial clinical study to assess the beneficial effects of its patent-pending ERGOFLEX™ joint health formula, launched commercially in December 2010.  Specifically, the study found that reduction of pain was statistically significant after as little as one week of ERGOFLEX use.  Similar improvements were seen with range of motion.  Benefits continued during the six weeks subjects took ERGOFLEX, and for some the benefits persisted during the subsequent six-week washout period.

ERGOFLEX is the only joint health complex containing the powerful antioxidant L-Ergothioneine (ERGO) and is specifically formulated to help the body fight the pain of joint inflammation and maintain optimal joint health. It is the first in a series of products built around the ERGO platform that are planned by OXIS.  

"These powerful and statistically significant final results strongly suggest that ERGOFLEX can provide significant quick and lasting relief from mild-to-moderate joint pain while improving range of motion, which results in an improved quality of life," said Bernie Landes, President of OXIS International.  "These clinically demonstrated results represent an important breakthrough for those tens of millions of Americans who suffer with chronic joint pain and diminished range of motion.  While most joint pain products only address the symptoms, ERGOFLEX targets and relieves oxidative stress, which frequently is the underlying cause of joint ailments. It also provides a suite of extensively researched natural ingredients that help maintain the structural integrity of joints and relieve pain."

The study included 12 subjects ta
'/>"/>

SOURCE OXIS International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
4. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
5. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
6. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
7. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
8. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
9. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
10. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
11. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... -- In accordance with Rule 17.1 and Rule 2.9 of ... States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today ... ELN). Background On 2 May 2013, ... the entire of the issued and to be issued share ... On 20 May 2013, Royalty Pharma announced the ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
... Codexis, Inc. (Nasdaq: CDXS ) today announced the company ... held in New York, NY on February 23-24, 2011. The presentation ... The company will also present at the Pacific Crest ... March 1-2, 2011. The presentation is scheduled for March 1 at ...
... 8, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... subsidiary, Biovail Laboratories International SRL (BLS), has entered into ... (dapsone) Gel 5%, a topical formulation of dapsone used ... will receive from BLS a CA$500,000 upfront payment to ...
Cached Medicine Technology:Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada 2Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada 3
(Date:5/24/2013)... 24, 2013 According to the new ... Global Forecasts (2011 - 2016)” published by MarketsandMarkets, global ... million by the end of year 2010 and is ... a CAGR of 17.9% from 2011 to 2016. , ... , 44 Figures , 370 ...
(Date:5/24/2013)... Just about any bodyweight training program includes a ... based in Dallas, GA that uses a variety of bodyweight ... is not used enough. , “The medicine ball pushup ... more challenging. By keeping your hands on a medicine ball, ... being worked much harder than a standard pushup. This unique ...
(Date:5/24/2013)... May 24, 2013 Child safety expert ... tips for end-of-year gifts for teachers that can "show ... child's life." Van der Zande is the founder of ... and resources, whose mission is to help people create ... , "Teachers have an incredible impact on the emotional ...
(Date:5/24/2013)... 2013 Patients who have chronic cough ... suffer from gastroesophageal reflux disease or GERD, West ... study published today. , The article, “Antireflux Surgery in ... Measured by Hypopharyngeal Multichannel Intraluminal Impedance” appears in ... great importance to individuals who live with a nagging ...
(Date:5/24/2013)... May 24, 2013 BroadConnect Telecom, ... video, data, and IT security solutions, present small ... communication costs by more than fifty percent (when ... Time Hosted PBX Bundle Pricing. BroadConnect’s hosted Voice ... touch with VoIP. , Starting today, until the ...
Breaking Medicine News(10 mins):Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 3Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 4Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2
... MONDAY, April 23 (HealthDay News) -- The experience of killing ... a study of U.S. veterans of the Vietnam War. ... sample of Vietnam War veterans and found that those with ... thoughts as those with fewer or no experiences of killing. ...
... (HealthDay News) -- The shingles vaccine is generally safe and ... Shingles, which affects more than 1 million people each year ... by the dormant chickenpox virus, which can reactivate and replicate, ... risk because immunity against the virus that causes shingles declines ...
... By Randy Dotinga HealthDay Reporter , MONDAY, ... a type of overactive thyroid condition appears to boost ... form of irregular heartbeat) and premature death. Patients ... known as subclinical hyperthyroidism, because it often doesn,t cause ...
... and Damon could be the kids up the block. Briana ... sister,s footsteps to college. Damon works hard at an after-school ... and try to stay out of trouble. , But Briana ... are a pair of digitally animated street-smart characters with a ...
... INDIANAPOLIS -- WellPoint announced today that Indiana University ... clinical expertise to help shape WellPoint,s new health ... to develop commercial applications utilizing IBM Watson to ... their efforts to make the most informed, personalized ...
... of the screw. That,s just a part of life for ... distraction osteogenesis, a method to correct bone deformities that leave ... Rice University undergraduates has invented a device they hope will ... Shriners Hospital for Children in Houston, the students came up ...
Cached Medicine News:Health News:Wartime Killing May Raise Veterans' Thoughts of Suicide 2Health News:Shingles Vaccine Safe, Underutilized, Study Says 2Health News:Thyroid Condition Linked to Heart Problems: Study 2Health News:Thyroid Condition Linked to Heart Problems: Study 3Health News:Animated characters keep it real in teen violence prevention videos 2Health News:Animated characters keep it real in teen violence prevention videos 3Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 3Health News:Rice University student engineers automate limb lengthening for kids 2Health News:Rice University student engineers automate limb lengthening for kids 3
Rhoton #12 straight point needle semisharp, titanium....
Micro 2000, micro scissors micro 2000 supercut....
Micro 2000 suture forceps light-weight instruments with blue-colored anodized round handles, extremely light weight, well balanced, easy to handle, fatigueless working, easy to maintain, corrosion-re...
Mini blades....
Medicine Products: